Cytogenomic Molecular Inversion Probe Array, FFPE Tissue - Products of Conception
For detection of copy number alterations and loss of heterozygosity in FFPE specimens from products of conception.
Molecular Inversion Probe Array
Fetal autopsy or products of conception.
FFPE Fetal tissue: Transport ten slides, each with 5 µm unstained sections or four 20 µm scrolls or tissue block.
OR FFPE villi: Transport one H&E stained slide and ten slides, each with 5 µm unstained sections or tissue block.
Room temperature. Also acceptable: Refrigerated. Ship in cooled container during summer months.
Specimens fixed or processed in alternative fixatives or heavy metal fixatives (B-4 or B-5).
Ambient: Indefinitely; Refrigerated: Indefinitely; Frozen: Unacceptable
For detection of copy number alterations and loss of heterozygosity in FFPE specimens.
Refer to report.
Laboratory Developed Test (LDT)
If sending placenta instead of fetal tissue, at least 80% villi for products of conception specimens.
This test must be ordered using Cytogenetic test request form #43098 or through your ARUP interface. Please submit the Patient History for Prenatal Cytogenetics form with the electronic packing list (https://ltd.aruplab.com/Tests/Pdf/65).
|Component Test Code*||Component Chart Name||LOINC|
|2010796||Cytogenomic MIP Array FFPE, POC|
|2010877||EER Cytogenomic MIP Array FFPE, POC||11526-1|
- array CGH
- Array Comparative Genomic Hybridization
- birth defects
- Chromosomal Microarray
- CMA; CGH
- Down syndrome
- Edward syndrome
- MCA; XO; 45,X; 45X
- multiple congenital anomalies
- Patau syndrome
- product of conception, POC, villi, placenta, fetal loss, fetal demise, abortion, pregnancy loss, sti
- Single-nucleotide-polymorphism (SNP) array
- T13; T18; T21
- trisomy 13
- Trisomy 18
- Trisomy 21
- Turner syndrome
- Whole Genome Array, formalin-fixed, paraffin-embedded, FFPE